{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:02:25Z","timestamp":1790539345444,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The mechanism by which <jats:italic>TSC2<\/jats:italic> inactivation or deficiency contributes to the pathology of tuberous sclerosis complex (TSC) is not fully clear. We show that renal angiomyolipomas from TSC patients and kidney cortex from <jats:italic>Tsc2<\/jats:italic>+\/\u2212 mice exhibit elevated levels of reactive oxygen species (ROS). Downregulation of tuberin (protein encoded by <jats:italic>TSC2<\/jats:italic> gene) in renal proximal tubular epithelial cells significantly increased ROS concomitant with enhanced Nox4. Similarly, we found elevated levels of Nox4 in the renal cortex of <jats:italic>Tsc2<\/jats:italic>+\/\u2212 mice and in the renal angiomyolipomas from TSC patients. Tuberin deficiency is associated with activation of mTORC1. Rapamycin, shRNAs targeting raptor, or inhibition of S6 kinase significantly inhibited the expression of Nox4, resulting in attenuation of production of ROS in tuberin-downregulated proximal tubular epithelial cells. In contrast, activation of mTORC1 increased Nox4 and ROS. These results indicate that Nox4 may be a potential target for tuberin-deficiency-derived diseases. Using a xenograft model from tuberin-null tubular cells in nude mice, both anti-sense Nox4 and GKT137831, a specific inhibitor of Nox1\/4, significantly inhibited the tumor growth. Thus, our results demonstrate the presence of an antagonistic relationship between tuberin and Nox4 to drive oncogenesis in the tuberin deficiency syndrome and identify Nox4 as a target to develop a therapy for TSC.<\/jats:p>","DOI":"10.1038\/s41598-018-21838-4","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T12:01:59Z","timestamp":1519300919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nox4 is a Target for Tuberin Deficiency Syndrome"],"prefix":"10.1038","volume":"8","author":[{"given":"Qian","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suryavathi","family":"Viswanadhapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Friedrichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakradhar","family":"Velagapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Szyndralewiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manzoor A.","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutam Ghosh","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna E.","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"21838_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble, C. C. et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Molecular cell 47, 535\u2013546, https:\/\/doi.org\/10.1016\/j.molcel.2012.06.009 (2012).","journal-title":"Molecular cell"},{"key":"21838_CR2","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1523-1755.2004.00838.x","volume":"66","author":"JJ Bissler","year":"2004","unstructured":"Bissler, J. J. & Kingswood, J. C. Renal angiomyolipomata. Kidney international 66, 924\u2013934, https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00838.x (2004).","journal-title":"Kidney international"},{"key":"21838_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-5347(01)63072-6","volume":"160","author":"DH Ewalt","year":"1998","unstructured":"Ewalt, D. H., Sheffield, E., Sparagana, S. P., Delgado, M. R. & Roach, E. S. Renal lesion growth in children with tuberous sclerosis complex. The Journal of urology 160, 141\u2013145 (1998).","journal-title":"The Journal of urology"},{"key":"21838_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/BF00856529","volume":"8","author":"LB Zimmerhackl","year":"1994","unstructured":"Zimmerhackl, L. B., Rehm, M., Kaufmehl, K., Kurlemann, G. & Brandis, M. Renal involvement in tuberous sclerosis complex: a retrospective survey. Pediatric nephrology 8, 451\u2013457 (1994).","journal-title":"Pediatric nephrology"},{"key":"21838_CR5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/jmg.33.6.480","volume":"33","author":"JA Cook","year":"1996","unstructured":"Cook, J. A., Oliver, K., Mueller, R. F. & Sampson, J. A cross sectional study of renal involvement in tuberous sclerosis. Journal of medical genetics 33, 480\u2013484 (1996).","journal-title":"Journal of medical genetics"},{"key":"21838_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","volume":"94","author":"FJ O\u2019Callaghan","year":"2004","unstructured":"O\u2019Callaghan, F. J., Noakes, M. J., Martyn, C. N. & Osborne, J. P. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU international 94, 853\u2013857, https:\/\/doi.org\/10.1111\/j.1464-410X.2004.05046.x (2004).","journal-title":"BJU international"},{"key":"21838_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1464-410X.1994.tb16577.x","volume":"74","author":"DW Webb","year":"1994","unstructured":"Webb, D. W., Kabala, J. & Osborne, J. P. A population study of renal disease in patients with tuberous sclerosis. British journal of urology 74, 151\u2013154 (1994).","journal-title":"British journal of urology"},{"key":"21838_CR8","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2174\/1566524043359610","volume":"4","author":"EP Henske","year":"2004","unstructured":"Henske, E. P. The genetic basis of kidney cancer: why is tuberous sclerosis complex often overlooked? Current molecular medicine 4, 825\u2013831 (2004).","journal-title":"Current molecular medicine"},{"key":"21838_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.eururo.2011.06.049","volume":"60","author":"B Ljungberg","year":"2011","unstructured":"Ljungberg, B. et al. The epidemiology of renal cell carcinoma. European urology 60, 615\u2013621, https:\/\/doi.org\/10.1016\/j.eururo.2011.06.049 (2011).","journal-title":"European urology"},{"key":"21838_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/PAS.0000000000000237","volume":"38","author":"P Yang","year":"2014","unstructured":"Yang, P. et al. Renal cell carcinoma in tuberous sclerosis complex. The American journal of surgical pathology 38, 895\u2013909, https:\/\/doi.org\/10.1097\/PAS.0000000000000237 (2014).","journal-title":"The American journal of surgical pathology"},{"key":"21838_CR11","first-page":"1206","volume":"59","author":"T Kobayashi","year":"1999","unstructured":"Kobayashi, T. et al. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer research 59, 1206\u20131211 (1999).","journal-title":"Cancer research"},{"key":"21838_CR12","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI7319","volume":"104","author":"H Onda","year":"1999","unstructured":"Onda, H., Lueck, A., Marks, P. W., Warren, H. B. & Kwiatkowski, D. J. Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. The Journal of clinical investigation 104, 687\u2013695, https:\/\/doi.org\/10.1172\/JCI7319 (1999).","journal-title":"The Journal of clinical investigation"},{"key":"21838_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1073\/pnas.90.1.327","volume":"90","author":"O Hino","year":"1993","unstructured":"Hino, O. et al. Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proceedings of the National Academy of Sciences of the United States of America 90, 327\u2013331 (1993).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"21838_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrc3339","volume":"12","author":"K Block","year":"2012","unstructured":"Block, K. & Gorin, Y. Aiding and abetting roles of NOX oxidases in cellular transformation. Nature reviews. Cancer 12, 627\u2013637, https:\/\/doi.org\/10.1038\/nrc3339 (2012).","journal-title":"Nature reviews. Cancer"},{"key":"21838_CR15","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.2337\/db07-1579","volume":"57","author":"S Simone","year":"2008","unstructured":"Simone, S., Gorin, Y., Velagapudi, C., Abboud, H. E. & Habib, S. L. Mechanism of oxidative DNA damage in diabetes: tuberin inactivation and downregulation of DNA repair enzyme 8-oxo-7,8-dihydro-2\u2032-deoxyguanosine-DNA glycosylase. Diabetes 57, 2626\u20132636, https:\/\/doi.org\/10.2337\/db07-1579 (2008).","journal-title":"Diabetes"},{"key":"21838_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/ki.2012.434","volume":"83","author":"Y Gorin","year":"2013","unstructured":"Gorin, Y. Nox4 as a potential therapeutic target for treatment of uremic toxicity associated to chronic kidney disease. Kidney international 83, 541\u2013543, https:\/\/doi.org\/10.1038\/ki.2012.434 (2013).","journal-title":"Kidney international"},{"key":"21838_CR17","doi-asserted-by":"publisher","unstructured":"Brandes, R. P., Weissmann, N. & Schroder, K. Nox family NADPH oxidases: Molecular mechanisms of activation. Free radical biology & medicine, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.07.046 (2014).","DOI":"10.1016\/j.freeradbiomed.2014.07.046"},{"key":"21838_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1042\/CS20130065","volume":"125","author":"Y Gorin","year":"2013","unstructured":"Gorin, Y. & Block, K. Nox as a target for diabetic complications. Clinical science 125, 361\u2013382, https:\/\/doi.org\/10.1042\/CS20130065 (2013).","journal-title":"Clinical science"},{"key":"21838_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2013.03.014","volume":"61C","author":"Y Gorin","year":"2013","unstructured":"Gorin, Y. & Block, K. Nox4 and diabetic nephropathy: With a friend like this, who needs enemies? Free radical biology & medicine 61C, 130\u2013142, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.03.014 (2013).","journal-title":"Free radical biology & medicine"},{"key":"21838_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/ars.2012.4886","volume":"20","author":"SI Dikalov","year":"2014","unstructured":"Dikalov, S. I. & Harrison, D. G. Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid Redox Signal 20, 372\u2013382, https:\/\/doi.org\/10.1089\/ars.2012.4886 (2014).","journal-title":"Antioxid Redox Signal"},{"key":"21838_CR21","doi-asserted-by":"publisher","first-page":"8038","DOI":"10.1073\/pnas.90.17.8038","volume":"90","author":"RS Yeung","year":"1993","unstructured":"Yeung, R. S., Buetow, K. H., Testa, J. R. & Knudson, A. G. Jr. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proceedings of the National Academy of Sciences of the United States of America 90, 8038\u20138042 (1993).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"21838_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","volume":"4","author":"JB Brugarolas","year":"2003","unstructured":"Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R. & Kaelin, W. G. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer cell 4, 147\u2013158, https:\/\/doi.org\/10.1016\/S1535-6108(03)00187-9 (2003).","journal-title":"Cancer cell"},{"key":"21838_CR23","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.2337\/db12-1504","volume":"62","author":"AA Eid","year":"2013","unstructured":"Eid, A. A. et al. Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes 62, 2935\u20132947, https:\/\/doi.org\/10.2337\/db12-1504 (2013).","journal-title":"Diabetes"},{"key":"21838_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10147-005-0551-4","volume":"11","author":"Y Tomita","year":"2006","unstructured":"Tomita, Y. Early renal cell cancer. International journal of clinical oncology 11, 22\u201327, https:\/\/doi.org\/10.1007\/s10147-005-0551-4 (2006).","journal-title":"International journal of clinical oncology"},{"key":"21838_CR25","first-page":"5645","volume":"62","author":"HL Kenerson","year":"2002","unstructured":"Kenerson, H. L., Aicher, L. D., True, L. D. & Yeung, R. S. Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. Cancer research 62, 5645\u20135650 (2002).","journal-title":"Cancer research"},{"key":"21838_CR26","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol 10, 307\u2013318, https:\/\/doi.org\/10.1038\/nrm2672 (2009).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"21838_CR27","doi-asserted-by":"publisher","first-page":"C597","DOI":"10.1152\/ajpcell.00331.2011","volume":"302","author":"RM Maalouf","year":"2012","unstructured":"Maalouf, R. M. et al. Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes. Am J Physiol-Cell Ph 302, C597\u2013C604, https:\/\/doi.org\/10.1152\/ajpcell.00331.2011 (2012).","journal-title":"Am J Physiol-Cell Ph"},{"key":"21838_CR28","doi-asserted-by":"publisher","first-page":"39616","DOI":"10.1074\/jbc.M502412200","volume":"280","author":"Y Gorin","year":"2005","unstructured":"Gorin, Y. et al. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. The Journal of biological chemistry 280, 39616\u201339626, https:\/\/doi.org\/10.1074\/jbc.M502412200 (2005).","journal-title":"The Journal of biological chemistry"},{"key":"21838_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","volume":"131","author":"QD Zhao","year":"2015","unstructured":"Zhao, Q. D. et al. NADPH Oxidase 4 Induces Cardiac Fibrosis and Hypertrophy Through Activating Akt\/mTOR and NFkappaB Signaling Pathways. Circulation 131, 643\u2013655, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011079 (2015).","journal-title":"Circulation"},{"key":"21838_CR30","doi-asserted-by":"publisher","first-page":"F1276","DOI":"10.1152\/ajprenal.00396.2014","volume":"308","author":"Y Gorin","year":"2015","unstructured":"Gorin, Y. et al. Targeting NADPH oxidase with a novel dual Nox1\/Nox4 inhibitor attenuates renal pathology in type 1 diabetes. American journal of physiology. Renal physiology 308, F1276\u20131287, https:\/\/doi.org\/10.1152\/ajprenal.00396.2014 (2015).","journal-title":"American journal of physiology. Renal physiology"},{"key":"21838_CR31","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","volume":"361","author":"N El-Hashemite","year":"2003","unstructured":"El-Hashemite, N., Zhang, H., Henske, E. P. & Kwiatkowski, D. J. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. Lancet 361, 1348\u20131349, https:\/\/doi.org\/10.1016\/S0140-6736(03)13044-9 (2003).","journal-title":"Lancet"},{"key":"21838_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471\u2013484, https:\/\/doi.org\/10.1016\/j.cell.2006.01.016 (2006).","journal-title":"Cell"},{"key":"21838_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler, J. J. et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. The New England journal of medicine 358, 140\u2013151, https:\/\/doi.org\/10.1056\/NEJMoa063564 (2008).","journal-title":"The New England journal of medicine"},{"key":"21838_CR34","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1681\/ASN.V12122585","volume":"12","author":"DM Attia","year":"2001","unstructured":"Attia, D. M. et al. Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. Journal of the American Society of Nephrology: JASN 12, 2585\u20132593 (2001).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"21838_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/hy0202.103264","volume":"39","author":"T Chabrashvili","year":"2002","unstructured":"Chabrashvili, T. et al. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39, 269\u2013274 (2002).","journal-title":"Hypertension"},{"key":"21838_CR36","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1161\/01.HYP.0000070028.99408.E8","volume":"41","author":"S Meng","year":"2003","unstructured":"Meng, S. et al. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41, 1346\u20131352, https:\/\/doi.org\/10.1161\/01.HYP.0000070028.99408.E8 (2003).","journal-title":"Hypertension"},{"key":"21838_CR37","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1084\/jem.20081297","volume":"205","author":"C Chen","year":"2008","unstructured":"Chen, C. et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205, 2397\u20132408, https:\/\/doi.org\/10.1084\/jem.20081297 (2008).","journal-title":"J Exp Med"},{"key":"21838_CR38","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/ni.2068","volume":"12","author":"K Yang","year":"2011","unstructured":"Yang, K., Neale, G., Green, D. R., He, W. & Chi, H. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nature immunology 12, 888\u2013897, https:\/\/doi.org\/10.1038\/ni.2068 (2011).","journal-title":"Nature immunology"},{"key":"21838_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1042\/bj3530411","volume":"353","author":"D Han","year":"2001","unstructured":"Han, D., Williams, E. & Cadenas, E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. The Biochemical journal 353, 411\u2013416 (2001).","journal-title":"The Biochemical journal"},{"key":"21838_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1371\/journal.pmed.0050008","volume":"5","author":"TF Cloughesy","year":"2008","unstructured":"Cloughesy, T. F. et al. Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-Deficient glioblastoma. Plos Med 5, 139\u2013151, https:\/\/doi.org\/10.1371\/journal.pmed.0050008 (2008).","journal-title":"Plos Med"},{"key":"21838_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1083\/jcb.200403069","volume":"166","author":"LS Harrington","year":"2004","unstructured":"Harrington, L. S. et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166, 213\u2013223, https:\/\/doi.org\/10.1083\/jcb.200403069 (2004).","journal-title":"J Cell Biol"},{"key":"21838_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4161\/cc.4.1.1343","volume":"4","author":"OJ Shah","year":"2005","unstructured":"Shah, O. J. & Hunter, T. Tuberous sclerosis and insulin resistance - Unlikely bedfellows reveal a TORrid affair. Cell Cycle 4, 46\u201351, https:\/\/doi.org\/10.4161\/cc.4.1.1343 (2005).","journal-title":"Cell Cycle"},{"key":"21838_CR43","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.2353\/ajpath.2010.090606","volume":"176","author":"K Block","year":"2010","unstructured":"Block, K. et al. The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin. Am J Pathol 176, 2447\u20132455, https:\/\/doi.org\/10.2353\/ajpath.2010.090606 (2010).","journal-title":"Am J Pathol"},{"key":"21838_CR44","first-page":"559A","volume":"23","author":"P Wiesel","year":"2012","unstructured":"Wiesel, P. et al. Safety and pharmacokinetics of single and multiple doses of a first in class dual NADPH oxidase 1 and 4 inhibitor administered orally in healthy subjects. Journal of the American Society of Nephrology: JASN 23, 559A (2012).","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"21838_CR45","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1074\/jbc.M111.246397","volume":"287","author":"F Das","year":"2012","unstructured":"Das, F. et al. Unrestrained Mammalian Target of Rapamycin Complexes 1 and 2 Increase Expression of Phosphatase and Tensin Homolog Deleted on Chromosome 10 to Regulate Phosphorylation of Akt Kinase. Journal of Biological Chemistry 287, 3808\u20133822, https:\/\/doi.org\/10.1074\/jbc.M111.246397 (2012).","journal-title":"Journal of Biological Chemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21838-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21838-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21838-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:52:21Z","timestamp":1671591141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21838-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21838"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21838-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3781"}}